Black Rock Inc. Aerovate Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 983,063 shares of AVTE stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

983,063

Previous 709,752 38.51%

Holding current value

$2.63 Million

Previous $21 Million 92.23%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.41 - $30.75 $385,368 - $8.4 Million	273,311 Added 38.51%	983,063 $1.63 Million
Q1 2024 May 10, 2024	SELL	$17.68 - $29.57 $312,971 - $523,448	-17,702 Reduced 2.43%	709,752 $21 Million
Q4 2023 Feb 13, 2024	BUY	$9.58 - $24.25 $427,967 - $1.08 Million	44,673 Added 6.54%	727,454 $16.5 Million
Q3 2023 Nov 13, 2023	BUY	$12.9 - $18.88 $775,728 - $1.14 Million	60,134 Added 9.66%	682,781 $9.27 Million
Q2 2023 Aug 11, 2023	BUY	$15.63 - $22.01 $353,988 - $498,482	22,648 Added 3.77%	622,647 $10.7 Million
Q1 2023 May 12, 2023	SELL	$19.17 - $27.7 $153,053 - $221,156	-7,984 Reduced 1.31%	599,999 $12.1 Million
Q4 2022 Feb 13, 2023	SELL	$15.92 - $30.52 $1.71 Million - $3.28 Million	-107,462 Reduced 15.02%	607,983 $17.8 Million
Q3 2022 Nov 14, 2022	BUY	$14.77 - $25.79 $148,837 - $259,885	10,077 Added 1.43%	715,445 $11.9 Million
Q2 2022 Aug 12, 2022	SELL	$10.8 - $16.91 $448,912 - $702,881	-41,566 Reduced 5.56%	705,368 $11 Million
Q1 2022 May 12, 2022	BUY	$8.25 - $18.33 $141,289 - $313,919	17,126 Added 2.35%	746,934 $13.7 Million
Q4 2021 Feb 10, 2022	BUY	$9.14 - $21.54 $2.26 Million - $5.32 Million	246,790 Added 51.09%	729,808 $8.61 Million
Q3 2021 Nov 09, 2021	BUY	$11.76 - $22.49 $5.68 Million - $10.9 Million	483,018 New	483,018 $10.1 Million

Others Institutions Holding AVTE

# of Institutions

Shares Held

4.48M

Call Options Held

Put Options Held

View Full List

About Aerovate Therapeutics, Inc.

Ticker AVTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,448,100
Market Cap $65.5M
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...

More about AVTE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account